Development Programs

---

LANA -CF  - Developing a novel long-acting subcutaneous peptide-based therapy for the treatment of Chronic Heart Failure

• Status - Preclinical Development

LANA-PL - Developing a novel long-acting aerosolized peptide-based therapy for the treatment of pulmonary diseases, including COPD, Asthma, and Pulmonary Hypertention

• Status - Preclinical Development

LASP - Developing a novel long-acting subcutaneous peptide-based therapy for the treatment of cardiovascular and metabolic diseases

• Status - Preclinical Development

LASC - Developing a novel long-acting subcutaneous peptide-based therapy for the treatment of cardiovascular diseases

• Status - Preclinical Development